Ritalin La Structural Formula. (Ritalin La 01)
Ritalin Capsule, Extended Release
Product Images NDC 0078-0371
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ritalin (NDC 0078-0371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Mean Plasma Concentration Time-profile Of Methylphenidate After A Single Dose Of Ritalin La 40 mg And Ritalin 20 mg Given In Two Doses 4 Hours Apart) (Ritalin La 02)
Figure 2: Kaplan-meier Investigator-determined Progression-free Survival Curves (Ritalin La 03)
The given text represents a comparison between the final and baseline scores of two groups, one treated with Ritalin LA (n=63) and the other with a placebo (n=71). The mean final score for the Ritalin LA group was 27 and for the placebo group was 28. The difference between the mean baseline score and the mean final score was -10.7 for the Ritalin LA group and 1.99 for the placebo group. The error bars represent the standard error of the mean.*
Principal Display Panel Ndc 0078-0424-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 10 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 04)
Ritalin LA is an extended-release medication in capsule form that contains methylphenidate HCI. This medication is used under prescription and is available in 10 mg doses packed in a container of 100 capsules with a medical guide attached. It's recommended to store the medication at room temperature of 20°C to 25°C (68°F to 77°F) and out of the reach of children. This drug is manufactured by Novartis Pharmaceuticals Corp. in New Jersey and distributed by Recro Gainesville LLC in Georgia. The dosage details can be found in the package insert.*
Principal Display Panel Ndc 0078-0370-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 20 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 05)
This is the label of a medication called Ritalin LA, made by Novartis. It is an extended-release capsule containing 20mg of methylphenidate HCI. The recommended dosage instructions are on the package insert. It should be stored in a tight container at temperatures between 20°C and 25°C (68°F to 77°F). Excursions are allowed between 15°C to 30°C (59°F to 86°F). The medication should be kept out of reach of children. This medication should be dispensed with a medication guide. The label also shows the manufacturing details.*
Principal Display Panel Ndc 0078-0371-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 30 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 06)
Ritalin LA (methylphenidate HCI) is an extended-release capsule available in 30mg strength with 100 capsules in a pack. This medication is dispensed with a medication guide, and it is available only with prescription. Detailed dosage instructions are included in the package. Novartis Pharmaceuticals Corp manufactures this medication, and it should be stored in a tight container at 20°C to 25°C (68°F to 77°F), with excursions permitted 15°C to 30°C (59°F to 86°F), as per USP Controlled Room Temperature guidelines. The contact address for manufacturing is Novartis Pharmaceuticals Corp, East Hanover, New Jersey 07936, by Recro Gainesville LLC, Gainesville, GA 30504. It is advised to keep this medicine, and all drugs children out of reach.*
Principal Display Panel Ndc 0078-0372-05 Rx Only Ritalin La® (methylphenidate HCl) Extended-release Capsules 40 mg 100 Tablets Dispense With Medication Guide Attached Or Provided Separately. Novartis (Ritalin La 07)
Ritalin LA is a medication used for attention-deficit/hyperactivity disorder. It comes in the form of extended-release capsules with a strength of 40mg. The medication guide should be provided when dispensing this drug. The dosage is detailed in the package insert. It must be stored in a tight container at 20°C to 25°C (68°F to 77°F) and kept out of reach of children. This particular product is manufactured by Recro Gainesville LLC under the name of Novartis Pharmaceuticals Corp.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
